Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For CXU.DE
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 23.91 1.33 1.08
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -31.09 5.06 7.35
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 7.77 16.75 15.54
Cash 2.86 1.43 1.39
Capex 54.01 -0.19 -0.41
Free Cash Flow 64.48 0.89 0.54
Revenue -0.31 6.14 6.16
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 2.49 0.46 0.45
Operating Margin 43.46 0.20 0.14
ROA 48.28 0.03 0.02
ROE 39.28 0.06 0.04
ROIC 42.61 0.04 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of CXU.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of CXU.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of CXU.DE is permitted for members.